OSL oncosil medical ltd

Your right current treatment is awful so maybe Oncosil would be...

  1. 16,867 Posts.
    lightbulb Created with Sketch. 836
    Your right current treatment is awful so maybe Oncosil would be preferable.

    As mentioned by Oncosil for Pancreatic Cancer
    Poor prognosis -Median survival ~8 months and 5 year survival less than 7%

    World market for pancreatic drugs is projected to exceed $1.2b by 2015

    Current Chemo regime in excess of $60,000 per annum

    High unmet medical need. • Pancreatic cancer has one year survival of 26%


    Oncosil results to date for Pancreatic Cancer

    Median overall survival was 309 days or 10+ months (compared with a typical 5.7 months with gemcitabine alone)

    Potential Market Size (>105,000 pts p.a)
    Total Market Opportunity for Oncosil in Pancreatic Cancer (>$1 Billion)

    OSL Cash reserves to Q4 2016, Directors invested substantial amounts higher than current price.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.16
Change
-0.070(5.69%)
Mkt cap ! $16.49M
Open High Low Value Volume
$1.25 $1.25 $1.11 $72.36K 60.96K

Buyers (Bids)

No. Vol. Price($)
1 9286 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.18 412 1
View Market Depth
Last trade - 16.10pm 27/06/2025 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.